Puma Biotechnology, Inc. (PBYI)
NASDAQ: PBYI · Real-Time Price · USD
3.010
+0.080 (2.73%)
At close: Apr 2, 2025, 4:00 PM
3.005
-0.005 (-0.16%)
After-hours: Apr 2, 2025, 7:09 PM EDT
Puma Biotechnology Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 69.22 | 84.59 | 76.2 | 63.13 | 85.29 | Upgrade
|
| Short-Term Investments | 31.75 | 11.35 | 4.87 | 18.98 | 8.1 | Upgrade
|
| Cash & Short-Term Investments | 100.97 | 95.94 | 81.07 | 82.11 | 93.39 | Upgrade
|
| Cash Growth | 5.24% | 18.34% | -1.26% | -12.08% | -16.35% | Upgrade
|
| Accounts Receivable | 32.01 | 47.84 | 40.35 | 32.53 | 25.54 | Upgrade
|
| Other Receivables | - | - | 1.92 | - | - | Upgrade
|
| Receivables | 32.01 | 47.84 | 42.27 | 32.53 | 25.54 | Upgrade
|
| Inventory | 8.72 | 7.08 | 4.53 | 7.11 | 3.45 | Upgrade
|
| Prepaid Expenses | 1.83 | 2.48 | 2.62 | 8.98 | 11.26 | Upgrade
|
| Restricted Cash | - | - | - | 8.85 | 8.85 | Upgrade
|
| Other Current Assets | 4.13 | 2.85 | 3.79 | 0.45 | 3.64 | Upgrade
|
| Total Current Assets | 147.66 | 156.19 | 134.28 | 140.02 | 146.14 | Upgrade
|
| Property, Plant & Equipment | 5.09 | 8.65 | 12.51 | 15.77 | 18.89 | Upgrade
|
| Other Intangible Assets | 51.13 | 60.87 | 70.61 | 66.13 | 74.14 | Upgrade
|
| Long-Term Deferred Tax Assets | 7.08 | - | - | - | - | Upgrade
|
| Long-Term Deferred Charges | 0.1 | 0.21 | - | 0.58 | 0.96 | Upgrade
|
| Other Long-Term Assets | 2.27 | 4.62 | 4.66 | 4.09 | 4.1 | Upgrade
|
| Total Assets | 213.33 | 230.53 | 222.06 | 226.59 | 244.22 | Upgrade
|
| Accounts Payable | 5.51 | 6.89 | 6.44 | 11.17 | 12.08 | Upgrade
|
| Accrued Expenses | 26.07 | 35.63 | 32.73 | 24.03 | 29.59 | Upgrade
|
| Current Portion of Long-Term Debt | 45.33 | 34 | - | - | 14.29 | Upgrade
|
| Current Portion of Leases | 5.54 | 4.8 | 4.14 | 3.57 | 3.09 | Upgrade
|
| Other Current Liabilities | 13.66 | 18.07 | 34.17 | 70.81 | 55.21 | Upgrade
|
| Total Current Liabilities | 96.11 | 99.38 | 77.48 | 109.59 | 114.26 | Upgrade
|
| Long-Term Debt | 21.72 | 65.66 | 98.31 | 97.09 | 84.03 | Upgrade
|
| Long-Term Leases | 1.49 | 7.03 | 11.83 | 15.98 | 19.55 | Upgrade
|
| Other Long-Term Liabilities | 1.88 | 5.01 | 12.83 | 6.38 | 32.34 | Upgrade
|
| Total Liabilities | 121.21 | 177.09 | 200.45 | 229.03 | 250.17 | Upgrade
|
| Common Stock | 0.01 | 0.01 | 0.01 | 0 | 0 | Upgrade
|
| Additional Paid-In Capital | 1,407 | 1,399 | 1,388 | 1,364 | 1,332 | Upgrade
|
| Retained Earnings | -1,315 | -1,345 | -1,367 | -1,367 | -1,338 | Upgrade
|
| Comprehensive Income & Other | 0.01 | -0 | - | -0 | - | Upgrade
|
| Shareholders' Equity | 92.13 | 53.44 | 21.61 | -2.45 | -5.95 | Upgrade
|
| Total Liabilities & Equity | 213.33 | 230.53 | 222.06 | 226.59 | 244.22 | Upgrade
|
| Total Debt | 74.08 | 111.49 | 114.28 | 116.64 | 120.95 | Upgrade
|
| Net Cash (Debt) | 26.88 | -15.55 | -33.21 | -34.54 | -27.57 | Upgrade
|
| Net Cash Per Share | 0.55 | -0.33 | -0.74 | -0.85 | -0.70 | Upgrade
|
| Filing Date Shares Outstanding | 49.61 | 48.21 | 46.64 | 41.33 | 40.26 | Upgrade
|
| Total Common Shares Outstanding | 49.11 | 47.65 | 46.35 | 41.18 | 40.09 | Upgrade
|
| Working Capital | 51.55 | 56.8 | 56.8 | 30.44 | 31.88 | Upgrade
|
| Book Value Per Share | 1.88 | 1.12 | 0.47 | -0.06 | -0.15 | Upgrade
|
| Tangible Book Value | 40.99 | -7.43 | -49 | -68.57 | -80.09 | Upgrade
|
| Tangible Book Value Per Share | 0.83 | -0.16 | -1.06 | -1.67 | -2.00 | Upgrade
|
| Machinery | 4.6 | 4.76 | 4.79 | 4.84 | 4.85 | Upgrade
|
| Leasehold Improvements | 3.78 | 3.78 | 3.78 | 3.78 | 3.78 | Upgrade
|
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.